We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Pebblebrook Hotel Trust
PEB
$2.15B
| $180K | ﹤0.01% |
13,470
+5,983
| +80% | +$91.4K |
|
|
SNV
1127
DELISTED
Synovus
SNV
| $180K | ﹤0.01% |
4,786
+673
| +16% | +$26.7K |
|
|
SPNS
1128
DELISTED
Sapiens International
SPNS
| $180K | ﹤0.01% |
9,747
+2,435
| +33% | +$45.8K |
|
1129
Diamondrock Hospitality Co
DRH
$2.71B
| $178K | ﹤0.01% |
21,751
+9,660
| +80% | +$84K |
|
1130
Watts Water Technologies
WTS
$11.5B
| $177K | ﹤0.01% |
1,211
+144
| +13% | +$20.7K |
|
1131
RLJ Lodging Trust
RLJ
$1.86B
| $176K | ﹤0.01% |
16,632
+7,386
| +80% | +$83.6K |
|
1132
Camtek
CAMT
$6.18B
| $175K | ﹤0.01% |
7,980
-1,134
| -12% | -$26.2K |
|
1133
Morningstar
MORN
$7.22B
| $175K | ﹤0.01% |
806
+78
| +11% | +$17.8K |
|
1134
SiteOne Landscape Supply
SITE
$4.12B
| $175K | ﹤0.01% |
1,489
+149
| +11% | +$17.4K |
|
1135
First American
FAF
$7.66B
| $172K | ﹤0.01% |
3,291
-39
| -1% | -$1.98K |
|
1136
Houlihan Lokey
HLI
$8.77B
| $172K | ﹤0.01% |
1,979
+176
| +10% | +$15.8K |
|
1137
Hubbell
HUBB
$25B
| $172K | ﹤0.01% |
732
-1,451
| -66% | -$348K |
|
1138
New York Times
NYT
$12.1B
| $172K | ﹤0.01% |
5,299
+376
| +8% | +$12.3K |
|
1139
Leonardo DRS
DRS
$12.3B
| $170K | ﹤0.01% |
+14,122
| New | +$164K |
|
1140
RLI Corp
RLI
$5.62B
| $169K | ﹤0.01% |
2,574
+96
| +4% | +$5.97K |
|
1141
FTI Consulting
FCN
$4.4B
| $167K | ﹤0.01% |
1,052
+96
| +10% | +$16K |
|
1142
Urban Edge Properties
UE
$2.86B
| $167K | ﹤0.01% |
11,865
+5,269
| +80% | +$75.7K |
|
1143
Ducommun
DCO
$2.7B
| $166K | ﹤0.01% |
3,332
-2,560
| -43% | -$122K |
|
1144
Datadog
DDOG
$95.4B
| $166K | ﹤0.01% |
+2,259
| New | +$176K |
|
1145
Glacier Bancorp
GBCI
$6.42B
| $166K | ﹤0.01% |
3,350
+327
| +11% | +$17.6K |
|
1146
InvenTrust Properties
IVT
$2.76B
| $166K | ﹤0.01% |
7,027
+3,121
| +80% | +$74.5K |
|
1147
Woodward
WWD
$21.3B
| $165K | ﹤0.01% |
1,707
+103
| +6% | +$9.52K |
|
1148
Atkore
ATKR
$2.46B
| $164K | ﹤0.01% |
1,443
+34
| +2% | +$3.56K |
|
1149
Eagle Materials
EXP
$6.29B
| $164K | ﹤0.01% |
1,234
+101
| +9% | +$12.8K |
|
1150
AMN Healthcare
AMN
$1.3B
| $163K | ﹤0.01% |
1,585
+202
| +15% | +$23.3K |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.